Prediction of optimal injection protocol for tumor detection in contrast-enhanced dynamic hepatic CT using simulation of lesion-to-liver contrast difference

Computerized Medical Imaging and Graphics

Volumn 24, Issue 5, 2000, Pages 317-327

  Kim, S ^a,b   Kim, J H ^b   Han, J K ^b   Lee, K H ^b   Min, B G ^a  

^a Seoul National University   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

Compartment model; Contrast agent; Hepatic CT; Injection protocol; Mass injection rate

Indexed keywords

CONTRAST MEDIA; IMAGE ANALYSIS; MEDICAL IMAGING; NETWORK PROTOCOLS; ONCOLOGY;

INJECTION PROTOCOLS;

COMPUTERIZED TOMOGRAPHY;

ARTICLE; CANCER DIAGNOSIS; COMPARTMENT MODEL; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC VALUE; INJECTION; LIVER CELL CARCINOMA; PRIORITY JOURNAL; SIMULATION;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; COMPUTER SIMULATION; CONTRAST MEDIA; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INJECTIONS, INTRAVENOUS; IOHEXOL; LIVER NEOPLASMS; MALE; MATHEMATICS; MIDDLE AGED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0034668332     PISSN: 08956111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-6111(00)00028-8     Document Type: Article

References (22)

1. Garcia P.A., Bonaldi V.M., Bret P.M., Liabg L., Reinhold C., Atri M. Effect of rate of contrast medium injection on hepatic enhancement at CT. Radiology. 199:1996;185-189.
2. Heiken J.P., Brink J.A., McClennan B.L., Sagel S.S., Forman H.P., DiCroce J. Dynamic contrast-enhanced CT of the liver: comparison of contrast medium injection rates and uniphasic and biphasic injection protocols. Radiology. 187:1993;327-331.
3. Berland L.L. Slip-ring and conventional dynamic hepatic CT: contrast material and timing considerations. Radiology. 195:1995;1-8.
4. Kuhns L.R. Optimal timing of abdominal CT in children: relationship to injection rate. Radiology. 189:1993;49-51.
5. Krause W. Application of pharmacokinetics to computed tomography. Investig Radiol. 31:1996;91-100.
6. Bae K.T., Heiken J.P., Brink J.A. Aortic and hepatic peak enhancement at CT: effect of contrast medium injection rate - pharmacokinetic analysis and experimental porcine model. Radiology. 206:1998;455-464.
7. Bae K.T., Heiken J.P., Brink J.A. Aortic and hepatic contrast medium enhancement at CT: Part I. Prediction with a computer model. Radiology. 207:1998;647-655.
8. Nakayama K., Matsuura H., Asai M., Ogawara K., Higaki K., Kimura T. Estimation of intradermal disposition kinetics of drugs: I. Analysis by compartment model with contralateral tissues. Pharm Res. 16:1999;302-308.
9. Hisaka A., Nakamura T., Sugiyama Y. Analysis of nonlinear hepatic clearance of a cyclopentapeptide, BQ-123, with the multiple indicator dilution method using the dispersion model. Pharm Res. 16:1999;103-109.
10. Groll A.H., Sein T., Petraitis V., Petraitiene R., Callender D., Gonzalez C.E., Giri N., Bacher J., Piscitelli S., Walsh T.J. Compartmental pharmacokinetics and tissue drug distribution of the pradimicin derivative BMS 181184 in rabbits. Antimicrob Agents Chemother. 42:1998;2700-2705.
11. Fukamura K., Yamaoka K., Higashimori H., Nakagama T. Analysis program based on finite element method, MULTI (FEM), for evaluation of dose dependant local disposition of drug in liver. J Pharm Sci. 88:1999;538-543.
12. Bellman R., Jacquez J.A., Kalaba R. Some mathematical aspects of chemotheraphy. II. The distribution of a drug in the body. Bull Math Biophys. 22:1960;309-322.
13. Bischoff K.B. Application of mathematical model for drug distribution in mammals Chemical engineering in medicine and biology. 1967;417-446 Plenum, New York.
14. Vander A.J., Sherman J.H., Luciano D.S. Human physiology: the mechanisms of body function. 5th ed. 1990;107-135 McGraw-Hill, New York.
15. Rideout V.C. Cardiovascular physiology system. 1991;27-65 Prentice-Hall, Englewood Cliffs, NJ.
16. Blomley M, Dawson P, Miles K. Functional computed tomography. Isis Medical Media Ltd, 1997. p. 47-55.
17. Gerlowski L., Jain R. Physiologically based pharmacokinetic modeling: principles and applications. J Pharm Sci. 72:1983;1103-1127.
18. Kim S., Lee K.H., Han J.K., Min B.G. Simulation of lesion to liver contrast difference curves in dynamic hepatic CT with pharmacokinetic compartment modeling. J Biomed Engng Res. 20:1999;173-181.
19. Deutsch S., Deutsch A. Understanding the nervous system, an engineering perspective. 1993;227-281 IEEE Press, New York.
20. Baron R.L. Understanding and optimizing use of contrast material for CT of the liver. AJR. 163:1994;323-331.
21. Schulthess GK, Hennig J. Functional imaging. PA: Lippincott-Raven, 1998. p. 25-47.
22. Irie T., Suzuki S., Yamauchi T., Kusano S. Prediction of the time to peak hepatic enhancement to optimize contrast-enhanced spiral CT. Acta Radiol. 36:1995;154-158.